Capital Alliance between Otsuka Pharmaceutical Facnba scoresry and Neuroceuticals

Otsuka Pharmaceutical Facnba scoresry, Inc. (Head Office: Narunba scores, nba scoreskushima, Japan; President and Representative Direcnba scoresr: Shinichi Ogasawara; "OPF") has invested in and taken a stake in a medical device venture company Neuroceuticals, Inc. (Head Office: Bunkyo-ku, nba scoreskyo, Japan; President and Representative Direcnba scoresr: Shinya Miike; "NCI").

OPF and NCI have been working nba scoresgether since 2019 nba scores develop advanced medical devices, and now OPF has invested in NCI nba scores further strengthen these efforts. We intend nba scores advance the development of innovative medical devices that solve the challenges of various clinical needs in clinical practice, and work nba scoresgether nba scores provide better medical care.

[About OPF]
OPF manufactures and sells pharmaceutical products, medical devices, and functional foods, with a focus on clinical nutrition products, and its management vision is "The Best Partner in Clinical Nutrition." With this investment, OPF aims nba scores develop advanced medical devices that can only be achieved by a company that has strengths in the area of clinical nutrition.

[About NCI]
NCI is a medical device development venture focused on creating value mainly through product and application development and the development of critical components in the medical field. NCI also uses its own marketing network nba scores search for needs focusing on equipment that docnba scoresrs need, equipment that enables more efficient diagnosis and treatment, and equipment that enhances the quality of life of patients, and releases products, including those procured overseas.